Angiopoietin-2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease

Hepatology ◽  
2019 ◽  
Vol 69 (3) ◽  
pp. 1087-1104 ◽  
Author(s):  
Sander Lefere ◽  
Frederique Van de Velde ◽  
Anne Hoorens ◽  
Sarah Raevens ◽  
Sanne Van Campenhout ◽  
...  
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Therapeutic Target ◽  
Fatty Liver Disease ◽  
Nonalcoholic Fatty Liver ◽  
Pathological Angiogenesis ◽  
Angiopoietin 2

Angiopoietin-2 levels correlates with disease activity in children with nonalcoholic fatty liver disease

2021 ◽  
Author(s):  
Melania Manco ◽  
Nadia Panera ◽  
Annalisa Crudele ◽  
Maria Rita Braghini ◽  
Marzia Bianchi ◽  
...  
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Disease Activity ◽  
Nonalcoholic Fatty Liver Disease ◽  
Fatty Liver Disease ◽  
Nonalcoholic Fatty Liver ◽  
Angiopoietin 2

scholarly journals SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease

2011 ◽  
Vol 17 (5) ◽  
pp. HY5-HY9 ◽  
Author(s):  
Yasar Colak ◽  
Oguzhan Ozturk ◽  
Ebubekir Senates ◽  
Ilyas Tuncer ◽  
Elif Yorulmaz ◽  
...  
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Therapeutic Target ◽  
Fatty Liver Disease ◽  
Potential Therapeutic Target ◽  
Nonalcoholic Fatty Liver
Sign in / Sign up

Export Citation Format

Share Document